memantine has been researched along with Catatonia in 10 studies
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We review the possible causes of catatonia and pharmacologic treatments for the condition and highlight the possible benefits of N-methylD-aspartic acid receptor antagonists such as memantine in the treatment of catatonia." | 6.47 | Memantine and catatonia: a case report and literature review. ( Catalano, G; Catalano, MC; Kahn, D; Obregon, DF; Velasco, RM; Wuerz, TP, 2011) |
| " This case demonstrates the safe use of memantine as an adjunctive agent in an adolescent with catatonia." | 5.72 | Safe Use of Memantine in a Pediatric Patient With Catatonia. ( Chaffkin, J; Josephs, IA; Katz, ER, 2022) |
| "A 59-year-old man with nonalcoholic steatohepatitis cirrhosis underwent an orthotopic liver transplant and experienced a complicated postoperative course, including a prolonged delirium." | 5.43 | Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. ( Brown, GD; Muzyk, AJ; Preud'homme, XA, 2016) |
| "Catatonia is a syndrome with protean manifestations and multiple aetiologies." | 5.37 | Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. ( Jean-Baptiste, M; Mukai, Y; Two, A, 2011) |
| "Sequential therapeutic trials for catatonoid frontal signs in clinically-evident frontotemporal dementia (n = 2) revealed differential benefits for lorazepam, amantadine, memantine, pramipexole, aripiprazole, quetiapine, citalopram, and donepezil, although certain signs also worsened." | 3.76 | Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. ( Greenway, LL; Kuppuswamy, PS; Lauterbach, EC, 2010) |
| "We review the possible causes of catatonia and pharmacologic treatments for the condition and highlight the possible benefits of N-methylD-aspartic acid receptor antagonists such as memantine in the treatment of catatonia." | 2.47 | Memantine and catatonia: a case report and literature review. ( Catalano, G; Catalano, MC; Kahn, D; Obregon, DF; Velasco, RM; Wuerz, TP, 2011) |
| " This case demonstrates the safe use of memantine as an adjunctive agent in an adolescent with catatonia." | 1.72 | Safe Use of Memantine in a Pediatric Patient With Catatonia. ( Chaffkin, J; Josephs, IA; Katz, ER, 2022) |
| "Catatonia is a severe motor syndrome found in approximately 10% of all acute psychiatric hospital admissions." | 1.43 | Catatonia and cannabis withdrawal: A case report. ( Amad, A; Caudron, M; Deheul, S; Geoffroy, PA; Rolland, B; Thomas, P, 2016) |
| "A 59-year-old man with nonalcoholic steatohepatitis cirrhosis underwent an orthotopic liver transplant and experienced a complicated postoperative course, including a prolonged delirium." | 1.43 | Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. ( Brown, GD; Muzyk, AJ; Preud'homme, XA, 2016) |
| "The diagnostic criteria of catatonia and frontotemporal dementia partly overlap." | 1.39 | Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy. ( Arai, H; Iseki, E; Utumi, Y, 2013) |
| "Catatonia is a syndrome with protean manifestations and multiple aetiologies." | 1.37 | Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. ( Jean-Baptiste, M; Mukai, Y; Two, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaffkin, J | 1 |
| Josephs, IA | 1 |
| Katz, ER | 1 |
| Naguy, A | 1 |
| Alamiri, B | 1 |
| Utumi, Y | 1 |
| Iseki, E | 1 |
| Arai, H | 1 |
| Ene-Stroescu, V | 1 |
| Nguyen, T | 1 |
| Waiblinger, BE | 1 |
| Caudron, M | 1 |
| Rolland, B | 1 |
| Deheul, S | 1 |
| Geoffroy, PA | 1 |
| Thomas, P | 1 |
| Amad, A | 1 |
| Brown, GD | 1 |
| Muzyk, AJ | 1 |
| Preud'homme, XA | 1 |
| Lauterbach, EC | 1 |
| Kuppuswamy, PS | 1 |
| Greenway, LL | 1 |
| Obregon, DF | 1 |
| Velasco, RM | 1 |
| Wuerz, TP | 1 |
| Catalano, MC | 1 |
| Catalano, G | 1 |
| Kahn, D | 1 |
| Mukai, Y | 1 |
| Two, A | 1 |
| Jean-Baptiste, M | 1 |
| Munoz, C | 1 |
| Yulan, N | 1 |
| Achaval, V | 1 |
| Appiani, F | 1 |
| Carroll, BT | 1 |
1 review available for memantine and Catatonia
| Article | Year |
|---|---|
Memantine and catatonia: a case report and literature review.
Topics: Aged, 80 and over; Catatonia; Depressive Disorder, Major; Dopamine Agents; Female; Humans; Memantine | 2011 |
9 other studies available for memantine and Catatonia
| Article | Year |
|---|---|
Safe Use of Memantine in a Pediatric Patient With Catatonia.
Topics: Adolescent; Amantadine; Benzodiazepines; Catatonia; Electroconvulsive Therapy; Humans; Memantine | 2022 |
Memantine for pediatric catatonia - Experience of Al-Manara CAP centre from Kuwait.
Topics: Catatonia; Child; Humans; Kuwait; Lorazepam; Memantine | 2023 |
Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy.
Topics: Aged; Atrophy; Catatonia; Combined Modality Therapy; Dopamine Agents; Electroconvulsive Therapy; Fem | 2013 |
Successful treatment of catatonia in a young man with schizophrenia and progressive diffuse cerebral atrophy.
Topics: Adolescent; Amantadine; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Atrophy; Catato | 2014 |
Catatonia and cannabis withdrawal: A case report.
Topics: Adult; Catatonia; Excitatory Amino Acid Antagonists; Humans; Hypnotics and Sedatives; Lorazepam; Mal | 2016 |
Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine.
Topics: Catatonia; Delirium; Excitatory Amino Acid Antagonists; Humans; Liver Transplantation; Male; Memanti | 2016 |
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinica | 2010 |
Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; Combined Modality Therapy; Do | 2011 |
Memantine in major depression with catatonic features.
Topics: Aged, 80 and over; Antiparkinson Agents; Catatonia; Depressive Disorder, Major; Female; Humans; Mema | 2008 |